mifepristone has been researched along with AIDS Seroconversion in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cabrera-Muñoz, E; Camacho-Arroyo, I; Fuentes-Romero, LL; Soto-Ramírez, LE; Zamora-Chávez, J | 1 |
Benton, T; Douglas, SD; Dubé, B; Evans, DL; Gettes, DR; Lai, JP; Lynch, KG; Metzger, D; Tustin, NB | 1 |
Davis, DS | 1 |
Forster, HP | 1 |
Cannold, L | 1 |
1 trial(s) available for mifepristone and AIDS Seroconversion
Article | Year |
---|---|
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biphenyl Compounds; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Glucocorticoids; HIV Seropositivity; Hormone Antagonists; Humans; Immunity, Innate; Killer Cells, Natural; Lymphocyte Count; Middle Aged; Mifepristone; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Substance P; T-Lymphocytes, Cytotoxic; Viral Load | 2008 |
4 other study(ies) available for mifepristone and AIDS Seroconversion
Article | Year |
---|---|
Effects of progesterone on the content of CCR5 and CXCR4 coreceptors in PBMCs of seropositive and exposed but uninfected Mexican women to HIV-1.
Topics: Adult; Cells, Cultured; Estradiol; Ethnicity; Female; HIV Infections; HIV Seropositivity; HIV-1; Hormone Antagonists; Humans; Leukocytes, Mononuclear; Middle Aged; Mifepristone; Progesterone; Receptors, CCR5; Receptors, CXCR4; Receptors, Progesterone | 2012 |
Legal trends in bioethics.
Topics: Abortion, Induced; Acquired Immunodeficiency Syndrome; Bioethical Issues; Bioethics; Brain Death; Child; Circumcision, Male; Cloning, Organism; Egypt; Euthanasia, Passive; Female; Government Regulation; Health Care Rationing; HIV Seropositivity; Human Experimentation; Humans; International Cooperation; Internationality; Japan; Jurisprudence; Managed Care Programs; Mifepristone; Organ Transplantation; Parents; Patient Selection; Persistent Vegetative State; Pharmaceutical Preparations; Physicians; Religion; Social Control, Formal; State Government; Suicide, Assisted; Supreme Court Decisions; Treatment Refusal; United States; Withholding Treatment; Women | 1997 |
Legal trends in bioethics.
Topics: Abortion, Induced; Bioethical Issues; Bioethics; Conflict of Interest; Contraception; Embryo Disposition; Embryo Research; Euthanasia; Euthanasia, Active; Euthanasia, Passive; Federal Government; Fertilization in Vitro; Geography; Government; Government Regulation; Health Care Rationing; HIV Seropositivity; Human Experimentation; Humans; International Cooperation; Internationality; Jurisprudence; Liability, Legal; Managed Care Programs; Mifepristone; Organ Transplantation; Parental Notification; Parents; Patient Selection; Pharmaceutical Preparations; Physicians; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Research; Resource Allocation; Scientific Misconduct; Social Change; Social Control, Formal; State Government; Suicide, Assisted; Treatment Refusal; United States | 1999 |
"There is no evidence to suggest...": changing the way we judge information for disclosure in the informed consent process.
Topics: Abortion, Induced; Australia; Cognition; Communication; Comprehension; Disclosure; Female; Feminism; Fertilization in Vitro; Freedom; HIV Seropositivity; Human Experimentation; Humans; Informed Consent; Jurisprudence; Mifepristone; Minority Groups; Personal Autonomy; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Probability; Reference Standards; Research Personnel; Research Subjects; Risk; Uncertainty; Women | 1997 |